###begin article-title 0
Loss of ATRX in Chondrocytes Has Minimal Effects on Skeletal Development
###end article-title 0
###begin p 1
Conceived and designed the experiments: NB FB. Performed the experiments: LAS JRL. Analyzed the data: LAS JRL. Wrote the paper: LAS JRL NB FB.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATRX</italic>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATRX</italic>
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mutations in the human ATRX gene cause developmental defects, including skeletal deformities and dwarfism. ATRX encodes a chromatin remodeling protein, however the role of ATRX in skeletal development is currently unknown.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 214 221 214 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2cre</sup>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
We induced Atrx deletion in mouse cartilage using the Cre-loxP system, with Cre expression driven by the collagen II (Col2a1) promoter. Growth rate, body size and weight, and long bone length did not differ in AtrxCol2cre mice compared to control littermates. Histological analyses of the growth plate did not reveal any differences between control and mutant mice. Expression patterns of Sox9, a transcription factor required for cartilage morphogenesis, and p57, a marker of cell cycle arrest and hypertrophic chondrocyte differentiation, was unaffected. However, loss of ATRX in cartilage led to a delay in the ossification of the hips in some mice. We also observed hindlimb polydactily in one out of 61 mutants.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 155 163 <span type="species:ncbi:9606">patients</span>
These findings indicate that ATRX is not directly required for development or growth of cartilage in the mouse, suggesting that the short stature in ATR-X patients is caused by defects in cartilage-extrinsic mechanisms.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATRX</italic>
###xml 120 123 120 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons1">[1]</xref>
###xml 125 128 125 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons2">[2]</xref>
###xml 306 309 302 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons2">[2]</xref>
###xml 365 368 361 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons3">[3]</xref>
###xml 449 452 445 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons4">[4]</xref>
###xml 560 563 556 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons4">[4]</xref>
###xml 648 651 644 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons2">[2]</xref>
###xml 749 752 745 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons2">[2]</xref>
###xml 898 901 894 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons4">[4]</xref>
###xml 1086 1089 1082 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons2">[2]</xref>
###xml 1138 1141 1134 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons4">[4]</xref>
###xml 1356 1359 1352 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Badens1">[5]</xref>
###xml 1539 1543 1535 1539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 1630 1633 1626 1629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Garrick1">[6]</xref>
###xml 1783 1786 1779 1782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Brub1">[7]</xref>
###xml 1788 1791 1784 1787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Seah1">[8]</xref>
###xml 1867 1870 1863 1866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Medina1">[9]</xref>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 469 477 <span type="species:ncbi:9606">patients</span>
###xml 537 545 <span type="species:ncbi:9606">patients</span>
###xml 585 593 <span type="species:ncbi:9606">patients</span>
###xml 763 771 <span type="species:ncbi:9606">patients</span>
###xml 953 961 <span type="species:ncbi:9606">patients</span>
###xml 1055 1063 <span type="species:ncbi:9606">patients</span>
ATR-X syndrome (Alpha-Thalassemia/Mental Retardation, X-linked) is a human disorder caused by mutations in the ATRX gene[1], [2]. Clinical manifestations include severe psychomotor and mental retardation, characteristic facial features, urogenital abnormalities, skeletal deformities and alpha-thalassemia [2]. Over 200 male ATR-X syndrome cases have been reported [3], and female carriers are unaffected due to the skewed pattern of X-inactivation [4]. ATR-X syndrome patients display a wide range of skeletal abnormalities, and 66% of patients show dwarfism [4]. About half of ATR-X patients have spinal deformities such as kyphosis or scoliosis [2]. Delayed bone age is characteristic of most cases studied by thorough radiological investigation [2]. For some patients, these skeletal abnormalities are apparent at birth, for others they manifest later in life, during the pubertal growth spurt [4]. Other skeletal deformities commonly seen in ATR-X patients include clinodactyly, brachydactyly, tapering of the fingers, overlapping digits, and 40% of patients have foot deformities [2]. A single case of bifid thumb has been reported [4]. Despite a broad characterization of the variety of physical and mental phenotypes, very few genotype/phenotype correlations have been established, and none are associated with the severity of skeletal deformities [5]. The molecular and genetic basis of these phenotypes are therefore unknown and it is unclear if these defects are due to a direct role of ATRX in the skeleton. Global knockout of Atrx using a ubiquitous GATA-Cre system leads to placental defects and embryonic lethality [6]. Conditional ablation of ATRX in the forebrain causes p53-dependent apoptotic cell death during embryogenesis, resulting in a smaller brain at birth [7], [8], while ATRX deficiency in the retina induces specific loss of interneurons [9].
###end p 9
###begin p 10
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Picketts1">[10]</xref>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Eisen1">[11]</xref>
###xml 409 412 409 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons4">[4]</xref>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Ritchie1">[12]</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Seah2">[13]</xref>
###xml 325 332 <span type="species:ncbi:9606">patient</span>
The ATRX protein contains a domain displaying high homology to SNF2 (Sucrose Non-Fermenting 2) proteins, suggesting a role as a chromatin remodeling protein [10]. The SNF family of proteins is involved in transcriptional regulation, maintenance of chromosome stability during mitosis and processing of DNA damage [11]. ATR-X patient mutations are generally hypomorphic and do not cause chromosomal instability[4]. However, depletion of ATRX in mammalian cells leads to defects in chromosome cohesion and mitotic progression [12]. In addition to its role during mitosis, ATRX appears to be involved in the regulation of gene expression [13].
###end p 10
###begin p 11
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-DeLise1">[14]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Yamaguchi1">[15]</xref>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Akiyama1">[16]</xref>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Hoffman1">[17]</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Kronenberg1">[18]</xref>
###xml 739 743 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Bobick1">[19]</xref>
###xml 991 995 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Bobick1">[19]</xref>
###xml 1314 1318 1314 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Ducy1">[20]</xref>
The development of long bones occurs through endochondral ossification, a highly regulated multi-step process initiated when pluripotent mesenchymal cells aggregate to form the beginning of a cartilage model [14]. Under the control of several transcription factors, such as Sox9, Sox5 and Sox6 [15], [16], mesenchymal cells differentiate into chondroblasts, which produce large quantities of type II collagen (Col2) [17]. Chondroblasts mature to form chondrocytes, which undergo rapid proliferation along the longitudinal axis of the future bone, forming the cartilage growth plate [18]. The differentiated chondrocytes in the center of the cartilage model undergo hypertrophy, increasing in cell size and secreting type X collagen (ColX) [19]. The hypertrophic chondrocytes encased in calcified ECM secrete vascular endothelial growth factor (VEGF), which recruits blood vessels bringing osteoblasts and osteoclasts to form the primary ossification center; and eventually undergo apoptosis [19]. Chondrocytes on either end of this primary ossification center continue to proliferate, enter hypertrophy and undergo apoptosis, thus allowing the bone to grow longitudinally. Finally, woven bone is laid down in the area of apoptotic chondrocytes and is remodeled by osteoblasts and osteoclasts to form lamellar bone [20].
###end p 11
###begin p 12
###xml 45 53 <span type="species:ncbi:9606">patients</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
To examine whether skeletal defects in ATR-X patients could be due to a requirement for ATRX in cartilage development, we examined the outcome of cartilage-specific inactivation of ATRX in mice, using the Cre-loxP system. Our findings demonstrate that loss of ATRX specifically in chondrocytes induces minor skeletal defects, but does not affect growth plate morphology and bone growth.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
ATRX is expressed in chondrocytes
###end title 14
###begin p 15
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n vivo</italic>
###xml 434 443 434 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g001">Figure 1A</xref>
###xml 664 673 664 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g001">Figure 1B</xref>
###xml 992 1001 992 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g001">Figure 1B</xref>
###xml 1016 1020 1016 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Ritchie1">[12]</xref>
###xml 1022 1026 1022 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Brub2">[21]</xref>
###xml 1132 1141 1132 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g002">Figure 2B</xref>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
Expression of ATRX in chondrocytes was assessed using in vitro and in vivo models. Immunohistochemistry of newborn (P0.5) and three week-old wild type mice demonstrated that ATRX is expressed throughout the cartilage growth plate. Strong nuclear staining of ATRX was apparent in all cartilage cells, but was most prominent in early hypertrophic chondrocytes. Lower levels of staining were observed in terminally differentiated cells (Figure 1A). Primary chondrocytes in monolayer culture were stained for ATRX by immunofluorescence. In interphase, we observed a punctate staining pattern within the nucleus that corresponded to bodies stained intensely with DAPI (Figure 1B, left panel). Alpha-tubulin (red) was used to visualize the location of the cytoplasm and to identify microtubules during cell division. During metaphase, ATRX was present exclusively at the edges of the aligned chromosomes, similar to the localization at pericentromeric heterochromatin reported in other cell types (Figure 1B, right panel) [12], [21]. Western blots of primary cultured chondrocytes showed that full-length ATRX was expressed in cartilage (Figure 2B).
###end p 15
###begin title 16
Expression and localization of ATRX in growth plate chondrocytes.
###end title 16
###begin p 17
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
(A) Immunostaining of ATRX in humerus growth plates of P0.5 and P21 mice. ATRX is seen in the nuclei of resting, proliferating and early hypertrophic cells in the growth plates (arrows). Scale bar: 100 microm. Regions of the growth plate are identified as resting (red arrow), proliferating (yellow), hypertrophic (green) and mineralized (blue). (B) Immunofluorescence detection of ATRX in primary mouse chondrocytes isolated from E15.5 long bones. Merged image of ATRX (green), DAPI (blue) and alpha-tubulin (red) reveals a punctate ATRX staining pattern restricted to the nucleus during interphase (left panel) and specific localization to condensed chromatin during mitosis (right panel). Scale bar: 10 microm.
###end p 17
###begin title 18
###xml 53 60 53 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 49 60 49 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Levels of ATRX are decreased in the cartilage of AtrxCol2Cre mice.
###end title 18
###begin p 19
###xml 91 98 91 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 87 98 87 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 457 460 457 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Garrick1">[6]</xref>
###xml 462 465 462 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Brub1">[7]</xref>
###xml 844 851 844 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 840 851 840 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 1039 1043 <span type="species:ncbi:10090">mice</span>
(A) RT-PCR analysis of RNA isolated from newborn rib cartilage (Cr) or brain (Br) from AtrxCol2Cre males (KO) and control littermates (Ctrl). Amplification was performed with primers flanking the loxP sites, in introns 17 and 20. The expected amplicon of 394 bp was obtained in control and an additional amplicon of 254 bp was obtained in KO cartilage caused by the recombination event. The levels of the recombined product are low, as described previously [6], [7], suggesting that this product is unstable. (B) Immunoblotting for Atrx from proteins isolated from newborn control and KO rib chondrocytes, calvariae and brain tissue. Atrx expression is greatly reduced in KO chondrocytes, but unaffected in calvariae and brain of KO animals. Beta-actin was used as a loading control. (C) Immunofluorescence detection of ATRX in control and AtrxCol2Cre primary chondrocytes isolated from newborn long bones shows the loss of ATRX protein in KO chondrocytes. Scale bar: 10 microm. (D) Immunohistochemistry on growth plates from P0.5 and P21 mice. ATRX staining is reduced in KO growth plates. Scale bar: 100 microm.
###end p 19
###begin title 20
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Loss of ATRX in mouse chondrocytes does not affect viability or growth
###end title 20
###begin p 21
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 178 181 178 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Brub1">[7]</xref>
###xml 279 285 279 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2a1</italic>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Terpstra1">[22]</xref>
###xml 441 445 441 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 566 575 566 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g002">Figure 2A</xref>
###xml 584 591 584 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">results</xref>
###xml 688 691 688 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Garrick1">[6]</xref>
###xml 693 696 693 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Brub1">[7]</xref>
###xml 853 860 853 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2cre</sup>
###xml 849 860 849 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2cre</sup></italic>
###xml 875 884 875 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g002">Figure 2B</xref>
###xml 1028 1034 1028 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2a1</italic>
###xml 1040 1049 1040 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g002">Figure 2B</xref>
###xml 1160 1167 1160 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 1156 1167 1156 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 1197 1206 1197 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g002">Figure 2C</xref>
###xml 1243 1250 1243 1250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 1239 1250 1239 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 1278 1287 1278 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g002">Figure 2D</xref>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 260 265 <span type="species:ncbi:10090">mouse</span>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 1191 1195 <span type="species:ncbi:10090">mice</span>
We utilized the Cre-LoxP system to generate mice with cartilage-specific inactivation of the Atrx gene. Female mice previously engineered with loxP sites flanking exon 18 of Atrx[7] were mated with male mice expressing Cre recombinase under the control of the mouse collagen II (Col2a1) promoter [22]. Reverse transcriptase PCR (RT-PCR) analysis of ATRX transcripts in cultured primary chondrocytes confirmed a strong reduction in wild type Atrx mRNA and the presence of low levels of a shorter transcript resulting from the recombination event in mutant cartilage (Figure 2A). These results confirm previous reports that the mRNA species generated by the recombination event is unstable [6], [7]. Levels of ATRX protein in chondrocytes from ribs of newborn mice were assessed by immunoblotting. ATRX protein amounts were substantially decreased in AtrxCol2cre chondrocytes (Figure 2B). In contrast, ATRX protein levels in brain and bone (calvariae) were unchanged in mutant mice, validating the tissue specific activity of the Col2a1 Cre (Figure 2B). Loss of ATRX protein was further confirmed by immunofluorescence of cultured chondrocytes isolated from AtrxCol2Cre and control littermate mice (Figure 2C) and by immunohistochemistry of AtrxCol2Cre and control growth plates (Figure 2D). These data showed that our breeding scheme resulted in specific and efficient loss of ATRX protein in cartilage.
###end p 21
###begin p 22
###xml 4 11 4 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 222 229 222 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 218 229 218 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 349 358 349 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g003">Figure 3A</xref>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
AtrxCol2Cre mice were obtained at expected Mendelian ratios, indicating that loss of ATRX in cartilage does not result in embryonic or neonatal lethality (59 control males, 61 KO males out of 29 litters). In addition, AtrxCol2Cre mice showed no significant difference in growth when weighed daily from birth to weaning and again at one year of age (Figure 3A), or in body length at three weeks of age compared to wild-type littermates (Ctrl: 6.30 cm STD: 0.21, KO: 6.17 cm STD: 0.38, p>0.05). Body length at 6 and 12 months was also unaffected (data not shown). Null males were capable of mating and producing offspring when backcrossed to floxed females to produce second-generation tissue-specific knockout mice.
###end p 22
###begin title 23
Effects of ATRX loss-of-function on growth and development of the skeleton.
###end title 23
###begin p 24
###xml 96 103 96 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 92 103 92 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
(A) Weight measurements from control and KO mice. No differences were seen in the growth of AtrxCol2Cre mice compared to control littermates, and weight gain was normal at all stages of development. (B, C) Skeletal stains of newborn and p21 control and KO mice showing cartilage (blue) and bone (red) proportions. Extent of limb ossification and skeletal proportions between control and mutant pups were unaffected at birth and at three weeks (D) Long bone lengths and skull proportions were measured from four control/KO littermate pairs at p21, and found to be unaffected by ATRX loss.
###end p 24
###begin p 25
###xml 232 243 232 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g003">Figure 3B,C</xref>
###xml 528 537 528 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g003">Figure 3D</xref>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
Skeletal preparations from newborn and weanling (21 day old) mice showed no change in skeletal morphology, bone length or extent of ossification, as determined by the ratio of Alizarin red to Alcian blue staining in the long bones (Figure 3B,C). Length of tibia, femur, radius, ulna, and humerus were measured, as well as the length and width of the skulls. Average measurements obtained from four independent littermate pairs revealed no significant changes in the length of long bone elements between control and mutant mice (Figure 3D).
###end p 25
###begin title 26
Growth plate morphology is not affected by the loss of ATRX
###end title 26
###begin p 27
###xml 86 93 86 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 82 93 82 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 300 309 300 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g004">Figure 4A</xref>
###xml 448 457 448 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g004">Figure 4B</xref>
###xml 662 671 662 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g004">Figure 4C</xref>
###xml 893 897 893 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Zhang1">[23]</xref>
###xml 978 987 978 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g004">Figure 4D</xref>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 1034 1038 <span type="species:ncbi:10090">mice</span>
Histochemical staining was conducted on paraffin sections of the growth plates of AtrxCol2Cre and control mice to examine proportions of resting, proliferative and hypertrophic zones. No difference in growth plate architecture or chondrocyte morphology was detected between genotypes at P0.5 or P21 (Figure 4A). In agreement with these data, no significant differences were seen in the length of any growth plate zone in three independent litters (Figure 4B). The early chondrogenic marker Sox9 was expressed in resting and proliferating chondrocytes of control and KO sections, demonstrating that loss of ATRX in growth plates had no effect on Sox9 expression (Figure 4C). To confirm that differentiation was unaffected in mutant chondrocytes, long bone sections were stained for p57, a cyclin-dependent protein kinase inhibitor that is expressed by prehypertrophic, postmitotic chondrocytes [23]. The pattern of p57-positive cells in the mutant growth plates at P0.5 and P21 (Figure 4D) was not different between control and mutant mice, suggesting that loss of ATRX in the cartilage growth plate does not affect terminal differentiation of chondrocytes. In addition, the expression of other cartilage markers such as ColX, Col2, or aggrecan was not altered at P0.5 or at P21 (data not shown), indicating that chondrocyte differentiation was unaffected by loss of ATRX expression in cartilage.
###end p 27
###begin title 28
ATRX-null growth plates are indistinguishable from controls.
###end title 28
###begin p 29
###xml 47 54 47 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 43 54 43 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
(A) Growth plate sections from control and AtrxCol2Cre mice at P0.5 and P21 were stained with safranin-O/Fast green, demonstrating unaltered growth plate architecture and morphology in mutant mice. Scale bar: 100 microm. (B) No significant difference in the length of the resting, proliferating or hypertrophic zones could be detected between genotypes at birth or weaning (N = 3 littermate pairs; two-tailed T-test). Error bars depict standard error of the mean (SEM). (C) Expression of Sox9, an early chondrocyte differentiation marker expressed in resting and proliferating chondrocytes, is not altered in the absence of ATRX at P0.5 or P21. Scale bar: 50 microm. (D) Immunohistochemistry for the differentiation marker p57 reveals that ATRX loss has no effect on the proportion of chondrocytes reaching terminal differentiation. Scale bar: 100 microm.
###end p 29
###begin title 30
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Conditional loss of ATRX in the mouse skeleton causes minor ossification defects
###end title 30
###begin p 31
###xml 81 88 81 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 77 88 77 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 295 304 295 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g005">Figure 5A</xref>
###xml 514 521 514 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 510 521 510 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
Although no overall changes in skeletal size or proportions were seen in the AtrxCol2Cre mice, minor delays in development were seen in some mice. Half (2/4) of the mutants examined by skeletal staining at day 21 displayed a delay in ossification of the union between the pubis and the ischium (Figure 5A). In those mutant mice where ossification was complete by day 21, the site of union was uneven with a spur-like bone projection. Both phenotypes suggest a mild defect in the ossification of the hip in the AtrxCol2Cre mice.
###end p 31
###begin title 32
###xml 30 37 30 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 26 37 26 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Minor defects observed in AtrxCol2Cre mice.
###end title 32
###begin p 33
###xml 44 51 44 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 40 51 40 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 147 152 <span type="species:ncbi:10090">mouse</span>
(A) Pelvis phenotype of P21 control and AtrxCol2Cre mice. Arrows indicate the site of delayed ossification in mutant mice. (B) Hind limb of mutant mouse with one additional digit, before and after skeletal preparation to stain for cartilage (blue) and bone (red). The additional digit is indicated by an arrow.
###end p 33
###begin p 34
###xml 49 56 49 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 45 56 45 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 97 106 97 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007106-g005">Figure 5B</xref>
A second phenotype observed in one of the 61 AtrxCol2Cremales was an extra digit in a hind foot (Figure 5B). This digit resembled an additional digit, similar to the fourth digit, rather than a bifurcation of the fifth toe. The toe appeared normal, and in skeletal preparations showed no gross differences from other digits.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 314 321 314 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 310 321 310 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
In this study, we show that loss of the ATRX protein specifically in cartilage of mice does not cause a major defect in skeletal growth or development. Although ATRX loss in the cartilage of mice was confirmed by immunohistochemistry, immunofluorescence and western blot analyses, we show that long bones from AtrxCol2Cre mice do not differ from controls in length or growth-plate morphology, and that these mice achieve the same adult length and weight as control littermates. Furthermore, mutant mice are viable and breed normally, with no defects seen in second-generation knockouts.
###end p 36
###begin p 37
###xml 107 114 107 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 103 114 103 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 179 186 179 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2Cre</sup>
###xml 175 186 175 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2Cre</sup></italic>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
Whole skeletal stains for ossified bone and cartilage were used to characterize the entire skeleton of AtrxCol2Cre mice. Qualitative and quantitative study of the control and AtrxCol2Cre skeletons showed no overall changes in cartilage proportions and lengths of individual elements.
###end p 37
###begin p 38
###xml 327 330 327 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Badens1">[5]</xref>
###xml 504 507 504 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Badens1">[5]</xref>
###xml 656 660 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Gibbons5">[24]</xref>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
###xml 280 288 <span type="species:ncbi:9606">patients</span>
###xml 383 391 <span type="species:ncbi:9606">patients</span>
###xml 553 561 <span type="species:ncbi:9606">patients</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
The minor defects observed in our mouse model suggest a mild effect from ATRX deficiency that may manifest only occasionally. This is not unexpected, as the limb and digit phenotypes observed in ATR-X syndrome patients are also highly variable. In a study of sixty-five unrelated patients, one case of bifid thumb was observed [5]. The varied hand and foot deformities in some ATR-X patients suggest that the effect on limb development may differ between individuals, even those with identical mutations [5]. Thorough radiologic investigations of ATR-X patients have shown that the most common phenotypic abnormalities were delayed bone age and coxa valga [24]. The delay in hip ossification seen in our mice may be due to a similar delay in bone age.
###end p 38
###begin p 39
###xml 108 111 108 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Garrick1">[6]</xref>
###xml 113 116 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Brub1">[7]</xref>
###xml 118 121 118 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Medina1">[9]</xref>
###xml 408 411 408 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Brub1">[7]</xref>
###xml 667 670 667 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Garrick1">[6]</xref>
###xml 1045 1048 1045 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Medina1">[9]</xref>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 854 858 <span type="species:ncbi:10090">mice</span>
###xml 1014 1022 <span type="species:ncbi:9606">patients</span>
Previous studies have shown that loss of ATRX in other tissues in the mouse causes severe and fatal defects [6], [7], [9]. Loss of ATRX in the mouse forebrain has been shown to result in widespread hypocellularity in the hippocampus and neocortex, as well as an overall reduction in forebrain size. These mice exhibit reduced weight and perinatal lethality, demonstrating the importance of ATRX in the brain [7]. Similarly, loss of ATRX in the 16-cell morula stage has revealed a specific and essential role for ATRX in the formation of the extraembryonic trophoblast in mice. Mutant mice showed a dramatic reduction in mitotic cells and early embryonic death at E9.5[6]. A third model examining the role of ATRX in the developing retina showed that ATRX loss-of-function leads to loss of interneurons, specifically, amacrine and horizontal cells. These mice demonstrated a defect in interneuron differentiation and survival, which is associated with functional deficits that may be similar to the subset of ATR-X patients with visual anomalies [9].
###end p 39
###begin p 40
This is the first study examining the specific loss of ATRX in the skeletal system, and surprisingly we observed only minor abnormalities. Since these effects are much less severe than in all other cell types examined, despite marked expression of ATRX in wild type chondrocytes, our data suggest cell type-specific requirement for ATRX function in cell survival and differentiation.
###end p 40
###begin p 41
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 387 391 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Garrick2">[25]</xref>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 553 556 553 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Brub1">[7]</xref>
###xml 558 561 558 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Seah1">[8]</xref>
###xml 569 572 569 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Medina1">[9]</xref>
###xml 163 171 <span type="species:ncbi:9606">patients</span>
###xml 427 432 <span type="species:ncbi:10090">mouse</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
###xml 691 699 <span type="species:ncbi:9606">patients</span>
One assumption in our model is that destabilization and subsequent breakdown of the Atrx mRNA is an accurate model of the hypomorphic gene expression seen in ATRX patients. While our model deletes only the long isoform of ATRX and retains the short isoform (ATRXt), it is unlikely that ATRXt has equivalent functions to the full length protein, as it lacks the functional SWI/SNF domain [25]. In addition, the same floxed Atrx mouse line has been used by us and others to successfully conduct loss of function studies in other organs, such as the brain [7], [8] or eye [9]. Since loss of ATRX does not affect cartilage development in mice, it seems likely that the skeletal defects in ATR-X patients are not due to direct effects of the mutant proteins in chondrocytes.
###end p 41
###begin p 42
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Logan1">[26]</xref>
###xml 638 642 638 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 914 918 914 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 1034 1038 1034 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Dacquin1">[27]</xref>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
###xml 765 772 <span type="species:ncbi:9606">patient</span>
###xml 878 886 <span type="species:ncbi:9606">patients</span>
We have used the cartilage-specific collagen II promoter, which is activated around embryonic day 9, for inactivation of the Atrx gene. However, there remains a possibility that some of the limb phenotypes seen in ATR-X patients (e.g. patterning defects affecting the digits) are due to an earlier effect, such as a function in formation or outgrowth of the limb bud or in formation of the initial mesenchymal cell template. Since loss of ATRX occurs later in development in our model, we cannot rule out such an earlier function for the protein. Use of an early limb bud-specific promoter, such as the Prx1 limb enhancer [26], to direct Atrx inactivation could answer this outstanding question. Additionally, a later deficiency may also contribute to the observed patient skeletal abnormalities. For example, defects in osteoblasts could contribute to delayed bone age seen in patients or reduced overall growth. Atrx deletion specifically in osteoblasts could be induced by using the a1(I)-collagen promoter to drive cre expression [27]. These experiments have been initiated in our laboratory.
###end p 42
###begin p 43
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Ballock1">[28]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Takeda1">[29]</xref>
###xml 666 670 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Takeda1">[29]</xref>
###xml 808 812 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Maestroni1">[30]</xref>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 124 132 <span type="species:ncbi:9606">patients</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
An alternative explanation for the surprising lack of skeletal defects in our mice is that the skeletal defects observed in patients might be secondary to abnormalities in other organs, such as neuroendocrine defects stemming from ATRX dysfunction in the nervous system [28]. There is much new evidence demonstrating that bone growth can be regulated centrally via cytokines, hormones and transcription factors, including the hormone leptin [29]. Experiments using leptin directly on bone cells have shown no effect on bone remodeling, however intracerebroventricular leptin infusion into leptin-deficient mice leads to an effect on bone mass via the nervous system [29]. Similarly, hematopoietic systems within the bone marrow have been shown to be influenced by the neurohormone melanin and catecholamines [30]. Both factors also have hematopoietic roles, and are present in substantial amounts in the bone marrow, supporting the idea that neural and neuroendocrine factors have a direct effect on the bone microenvironment. Together, these studies suggest that cell defects in the hypothalamus (in the case of leptin) or the pineal gland (in the case of melatonin) may have a central influence on the development and homeostasis of the skeleton.
###end p 43
###begin p 44
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Importantly, it appears likely that the large variety of skeletal and growth abnormalities in ATRX patients does not have one common cellular origin; instead it appears that some defects (e.g. digit malformations) could be due to alterations in the early patterning of the limb, others (such as delayed bone age) could be caused by defects in osteoblasts (or possibly osteoclasts) and a third group (such as growth retardation) could be caused by abnormal neuroendocrine signaling. These possibilities will require examination as alternative mechanisms for the pathogenesis of ATR-X syndrome.
###end p 44
###begin title 45
Materials and Methods
###end title 45
###begin title 46
Histology and immunohistochemistry
###end title 46
###begin p 47
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Wang1">[32]</xref>
###xml 136 137 136 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 138 139 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 308 312 <span type="species:ncbi:9925">goat</span>
###xml 440 444 <span type="species:ncbi:9925">goat</span>
###xml 522 533 <span type="species:ncbi:3704">horseradish</span>
Histology and immunohistochemistry procedures were performed as described [32] with minor modifications. Sections were incubated in 3% H2O2 for 15 min at room temperature, followed by boiling for 2 min and incubation for 20 min at 97degreesC in 10 mM sodium citrate (pH 6.0). Sections were incubated with 5% goat serum for 30 min, and subsequently with primary antibodies (ATRX D-19) at a dilution of 1:50 overnight at 4degreesC. Secondary goat antibodies were used to recognize the primary antibodies. After washing, the horseradish peroxidase (HRP) conjugated polymer complex was visualized by incubation for 2 to 10 min with 3,3''-diaminobenzidine (DAB) substrate-chromogen. Sections were counterstained with methyl green, washed and mounted.
###end p 47
###begin p 48
All images were taken at room temperature with a Retiga EX camera (Leeds Precision Instruments, Inc.) connected to a DMRA2 microscope (Leica). Image analysis was performed using Openlab 4.0.4 software (Improvision).
###end p 48
###begin p 49
###xml 340 344 <span type="species:ncbi:10090">mice</span>
Growth plate morphology was analyzed by Safranin-O stain on P0.5 and P21 long bone sections. Sections were dewaxed, stained in hematoxylin followed by staining in fast green and safranin-O. Proportions of resting, proliferating and hypertrophic cells were determined using Openlab 4.0.4 software (Improvision) from at least three different mice.
###end p 49
###begin title 50
Immunofluorescence of cultured primary chondrocytes
###end title 50
###begin p 51
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-James1">[33]</xref>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 551 555 <span type="species:ncbi:9925">goat</span>
###xml 683 688 <span type="species:ncbi:10090">mouse</span>
###xml 772 778 <span type="species:ncbi:9986">rabbit</span>
###xml 809 814 <span type="species:ncbi:10090">mouse</span>
Primary chondrocytes were prepared from long bones of E15.5 mouse embryos[33]. Briefly, long bones were dissected, rinsed in PBS and incubated at 37degreesC for 20 min in trypsin-EDTA followed by digestion with 2 mg/ml collagenase P at 37degreesC for 2 h in Dulbecco's Modified Eagles Medium (DMEM) with 10% FBS. The cell suspension was filtered through a 70 mum cell strainer (Falcon), washed, counted and plated. For ATRX immunofluorescence, cells were grown on glass coverslips and fixed for 15 minutes in 4% paraformaldehyde, then blocked with 5% goat serum for 30 min at room temperature. Cells were then incubated with ATRX antibody at a 1:300 dilution (H-300, Santa Cruz) and mouse anti-alpha tubulin at a 1:10,000 dilution (Sigma) followed by FITC-conjugated anti-rabbit and Alexa 594-conjugated anti-mouse secondary antibodies. Slides were mounted in media containing DAPI and images were acquired on a Leica DMI 6000 b automated inverted microscope.
###end p 51
###begin title 52
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse breeding and genotyping
###end title 52
###begin title 53
Ethics Statement
###end title 53
###begin p 54
All procedures involving animals were approved by the University of Western Ontario Animal Care and Use Committee.
###end p 54
###begin p 55
###xml 166 170 166 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP</sup>
###xml 162 170 162 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>LoxP</sup></italic>
###xml 199 202 199 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Garrick1">[6]</xref>
###xml 221 230 221 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2a1Cre</italic>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Terpstra1">[22]</xref>
###xml 405 406 405 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 95 99 <span type="species:ncbi:10090">Mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
Mice were exposed to a 12-hour light-dark cycle and fed tap water and regular chow ad libitum. Mice conditionally deficient in ATRX were generated by crossing of AtrxLoxP females (129 sv background) [6] with heterozygous Col2a1Cre-knock-in male mice [22]. For developmental studies, midday of the day of vaginal plug discovery was considered E0.5. At scheduled times pregnant females were sacrificed by CO2.
###end p 55
###begin p 56
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Terpstra1">[22]</xref>
###xml 264 268 264 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 308 311 308 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Seah1">[8]</xref>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Terpstra1">[22]</xref>
###xml 378 381 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sry</italic>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 514 540 514 540 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GATCGGCCATTGAACAAGAT-3&#8242;</named-content>
###xml 545 573 545 573 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATA GGT CGG CGG TTC AT-3&#8242;</named-content>
###xml 598 630 598 630 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCC GAG TAT CTG GAA GAC AG-3&#8242;</named-content>
###xml 635 663 635 663 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATA GGT CGG CGG TTC AT-3&#8242;</named-content>
###xml 716 748 716 748 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCT GGA AAA TGC TTC TGT CC-3&#8242;</named-content>
###xml 755 788 755 788 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAG GGT GTT ATA AAC AAT CCC-3&#8242;</named-content>
###xml 858 890 858 890 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCA GGT GGA AAA GCC TTA CA-3&#8242;</named-content>
###xml 897 929 897 929 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAG CTT TGC TGG TTT TG GA -3&#8242;</named-content>
###xml 962 965 962 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sry</italic>
###xml 1121 1124 1091 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 1129 1132 1099 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sry</italic>
###xml 1257 1261 1197 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
PCR genotyping was performed from ear biopsy DNA for the presence of the Cre transgene as previously described [22]. Genotyping of embryonic and newborn mice was performed using PCR of DNA isolated from skin biopsies. PCR amplification was performed to detect the Atrx floxed alleles as previously described [8], the Cre transgene [22], as well as the sex determining region Y (Sry) gene to identify male mice. A 1.5 kb fragment of neo gene within the floxed allele of Atrx was identified with one set of primers (5'-GATCGGCCATTGAACAAGAT-3' and 5'-ATA GGT CGG CGG TTC AT-3') whereas the other set (5'-CCC GAG TAT CTG GAA GAC AG-3' and 5'-ATA GGT CGG CGG TTC AT-3') amplified a 600 bp fragment of wild type. Primers (5'-CCT GGA AAA TGC TTC TGT CC-3') and (5'-CAG GGT GTT ATA AAC AAT CCC-3') amplified a 300 bp fragment of the cre gene, whereas the other set (5'-GCA GGT GGA AAA GCC TTA CA-3') and (5'-AAG CTT TGC TGG TTT TG GA -3') amplified a 250 bp fragment of Sry. PCR conditions were as follows: 95degreesC for 3 min (95degreesC for 30 s, 55degreesC for 45 s, and 72degreesC for 1 min) x 36, 72degreesC for 10 min for Cre and Sry, 95degreesC for 3 min (95degreesC for 30 s, 55degreesC for 1 min, and 72degreesC for 5 min) x 36, 72degreesC for 10 min for Atrx.
###end p 56
###begin title 57
Skeletal stains and measurements
###end title 57
###begin p 58
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Wang1">[32]</xref>
###xml 5 9 <span type="species:ncbi:10090">mice</span>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
Live mice were weighed at P0, P7 and P21. Whole body length was measured using a ruler after sacrifice. For Alizarin Red/Alcian Blue staining, mouse carcasses were skinned and eviscerated, then fixed overnight in 95% ethanol followed by overnight fixation in acetone. Whole skeletons were placed in staining solution for 7-10 days (0.05% Alizarin Red, 0.015% Alcian Blue, 5% acetic acid in 70% ethanol)[32]. Skeletons were then cleared in 2% KOH. Images of stained bones were obtained with an Olympus SP-57OUZ. Limb bones and skulls from four different littermate pairs were measured using a dissecting microscope with a ruler.
###end p 58
###begin title 59
RT-PCR
###end title 59
###begin p 60
###xml 47 54 47 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col2cre</sup>
###xml 43 54 43 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx<sup>Col2cre</sup></italic>
###xml 217 221 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 245 279 245 279 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; &#8211;AGA ACC GTT AGT GCA GGT TCA-3&#8242;</named-content>
###xml 302 335 302 335 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACC ACC ATC TTC TTG CCA TC -3&#8242;</named-content>
Five micrograms of total RNA obtained from AtrxCol2cre and littermate control chondrocytes and control brains was reverse-transcribed using Omniscript RT kit (Qiagen) and used for PCR amplification with the following Atrx-specific primers: 17F (5' -AGA ACC GTT AGT GCA GGT TCA-3') for exon 17 and 20a (5'-ACC ACC ATC TTC TTG CCA TC -3') for exon 20. Conditions for amplification were as follows: 95degreesC for 3 min (95degreesC for 30 s, 56degreesC for 30 s, and 72degreesC for 1 min) x 32, 72degreesC for 10 min.
###end p 60
###begin title 61
Western blot analysis
###end title 61
###begin p 62
###xml 260 264 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007106-Beier1">[34]</xref>
###xml 367 368 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 611 612 610 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 1018 1024 <span type="species:ncbi:9986">rabbit</span>
###xml 1102 1113 <span type="species:ncbi:3704">horseradish</span>
###xml 1320 1325 <span type="species:ncbi:10090">mouse</span>
Primary rib cartilage was isolated from newborn mice. Ribs were dissociated using collagenase P and strained through a 70mum nylon filter to remove ossified tissue, followed by 3 days in culture over 1.5% agarose in PBS to specifically select for chondrocytes [34]. All tissues were lysed with MITO buffer (20 mM HEPES pH 7.5, 1 mM EDTA pH 8.0, 10 mM KCl, 1.5 mM MgCl2 and 1 protease inhibitor cocktail tablet [Complete mini, EDTA-free; Roche]), followed by treatment and lysis of nuclei with nuclear buffers without and with salt, respectively (20 mM HEPES pH 7.9, 450 mM NaCl (omitted for no salt) 1.5 mM MgCl2, 0.2 mM EDTA pH 8.0 and 1 protease inhibitor cocktail tablet). Nuclear buffer without salt was used for swelling nuclei, nuclear buffer with salt used for 25 minute nuclear lysis on ice. Extracts were quantified using the BCA protein assay (Sigma-Aldrich). Protein (5 mug) was resolved on a 6 % SDS-PAGE and transferred onto nitrocellulose membranes (Bio-Rad Laboratories). The membranes were probed with rabbit alpha-ATRX H300 (Santa Cruz Biotechnology, Inc.) followed by the appropriate horseradish peroxidase-conjugated secondary antibody (1:5,000; GE Healthcare). After washing, the membrane was incubated in ECL before exposure using a ChemiImager 5500 (Alpha Innotech). The membrane was reprobed with mouse anti-beta-actin (1:10,000; Sigma-Aldrich) as a loading control.
###end p 62
###begin p 63
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atrx</italic>
###xml 72 76 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP</sup>
###xml 35 42 <span type="species:ncbi:9581">Gibbons</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
We thank Douglas Higgs and Richard Gibbons for the kind gift of the AtrxLoxP mice.
###end p 63
###begin title 64
References
###end title 64
###begin article-title 65
Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome).
###end article-title 65
###begin article-title 66
Clinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X).
###end article-title 66
###begin article-title 67
Mutations in the chromatin-associated protein ATRX.
###end article-title 67
###begin article-title 68
Molecular-clinical spectrum of the ATR-X syndrome.
###end article-title 68
###begin article-title 69
###xml 130 138 <span type="species:ncbi:9606">patients</span>
Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome.
###end article-title 69
###begin article-title 70
Loss of Atrx Affects Trophoblast Development and the Pattern of X-Inactivation in Extraembryonic Tissues.
###end article-title 70
###begin article-title 71
The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis.
###end article-title 71
###begin article-title 72
Neuronal death resulting from targeted disruption of the Snf2 protein ATRX is mediated by p53.
###end article-title 72
###begin article-title 73
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
Altered visual function and interneuron survival in Atrx knockout mice: inference for the human syndrome.
###end article-title 73
###begin article-title 74
ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome.
###end article-title 74
###begin article-title 75
Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions.
###end article-title 75
###begin article-title 76
Loss of ATRX leads to chromosome cohesion and congression defects.
###end article-title 76
###begin article-title 77
Neuronal Death Resulting from Targeted Disruption of the Snf2 Protein ATRX Is Mediated by p53.
###end article-title 77
###begin article-title 78
Cellular interactions and signaling in cartilage development Osteoarthritis and Cartilage
###end article-title 78
###begin article-title 79
Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1.
###end article-title 79
###begin article-title 80
The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.
###end article-title 80
###begin article-title 81
Molecular mechanisms regulating chondroblast differentiation.
###end article-title 81
###begin article-title 82
Developmental regulation of the growth plate.
###end article-title 82
###begin article-title 83
Regulation of cartilage formation and maturation by Mitogen-Activated Protein Kinase signaling.
###end article-title 83
###begin article-title 84
The Osteoblast: A Sophisticated Fibroblast under Central Surveillance.
###end article-title 84
###begin article-title 85
###xml 125 130 <span type="species:ncbi:9606">Human</span>
Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association Human Molecular Genetics
###end article-title 85
###begin article-title 86
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes.
###end article-title 86
###begin article-title 87
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome.
###end article-title 87
###begin article-title 88
Alpha thalassaemia-mental retardation, X linked.
###end article-title 88
###begin article-title 89
A conserved truncated isoform of the ATR-X syndrome protein lacking the SWI/SNF-homology domain.
###end article-title 89
###begin article-title 90
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer.
###end article-title 90
###begin article-title 91
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
###end article-title 91
###begin article-title 92
Physiology and pathophysiology of the growth plate.
###end article-title 92
###begin article-title 93
Central control of bone remodeling.
###end article-title 93
###begin article-title 94
Neurohormones and Catecholamines as Functional Components of the Bone Marrow Microenvironment.
###end article-title 94
###begin article-title 95
The genetic basis for skeletal diseases.
###end article-title 95
###begin article-title 96
Genetic ablation of Rac1 in cartilage results in chondrodysplasia Developmental Biology
###end article-title 96
###begin article-title 97
Expression profiling of Dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development.
###end article-title 97
###begin article-title 98
Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes.
###end article-title 98
###begin p 99
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 99
###begin p 100
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 92 100 <span type="species:ncbi:9606">Children</span>
###xml 588 596 <span type="species:ncbi:9606">Children</span>
Funding: This work was supported by funds from the Lawson Health Research Institute and the Children's Health Research Institute. L.S. was supported by the Ontario Graduate Studentships in Science and Technology and a Curtis Cadman Studentship Award. J.R.L. was supported by a summer studentship from the Canadian Institutes of Health Research (CIHR)/Institute for Musculoskeletal Health and Arthritis (IMHA). N.G.B. is the recipient of a CIHR New Investigator Award, and F.B. is a Canada Research Chair. This work was supported by funds from the Lawson Health Research Institute and the Children's Health Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 100

